Invention Grant
US07390658B2 CD8α+lymphoid dendritic cell differentiated from human hematopoietic stem cell and a method for differentiation
有权
CD8alpha +淋巴样树突状细胞分化人造血干细胞和分化方法
- Patent Title: CD8α+lymphoid dendritic cell differentiated from human hematopoietic stem cell and a method for differentiation
- Patent Title (中): CD8alpha +淋巴样树突状细胞分化人造血干细胞和分化方法
-
Application No.: US10473839Application Date: 2002-03-28
-
Publication No.: US07390658B2Publication Date: 2008-06-24
- Inventor: Hyun-Soo Kim , Kyung-Bock Lee , Hugh-Chul Kim
- Applicant: Hyun-Soo Kim , Kyung-Bock Lee , Hugh-Chul Kim
- Applicant Address: KR KR KR KR
- Assignee: Lifecord, Inc.,FCB-Pharmicell Co., Ltd.,Hugh Chul Kim,Hyun-Soo Kim
- Current Assignee: Lifecord, Inc.,FCB-Pharmicell Co., Ltd.,Hugh Chul Kim,Hyun-Soo Kim
- Current Assignee Address: KR KR KR KR
- Agency: Baker & Hostetler, LLP
- Priority: KR2001-16569 20010329
- International Application: PCT/KR02/00544 WO 20020328
- International Announcement: WO02/078599 WO 20021010
- Main IPC: C12N5/08
- IPC: C12N5/08
Abstract:
Lymphoid dendritic cells with immunophenotype CD8α+ can be produced by a method which comprises culturing human hematopoietic stem cells in a medium containing GM-CSF, followed by culturing in a medium containing IFN-Υ, the lymphoid dendritic cells being useful in various immunotherapies.
Public/Granted literature
Information query
